Lipoproteinapherese bei schwerer Hypercholesterinämie – Wenn Diät und Medikamente nicht ausreichen

• Literatur

• 1 März W, Kreuzer J. Wenn Pharmaka nicht ausreichen: Stellenwert der Lipidapherese in der Behandlung der schweren Hypercholesterinämie. Der Lipidreport 2002; 11: 3
• 2 Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-239
• 3 Bosch T, Schmidt B, Kleophas W et al. LDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood. Artif Organs 1997; 21: 977-981
• 4 Dräger LJ, Julius U, Kraenzle K et al. DALI-the first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results. Eur J Clin Invest 1998; 28: 994-1002
• 5 Bosch T, Gahr S, Belschner U et al. Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions. Ther Apher Dial 2006; 10: 210-218
• 6 Schuff-Werner P. Heparin-induzierte extrakorporale LDLPräzipitation (HELP). In: Schwandt P, Richter WO, Parhofer KG, Hrsg. Handbuch der Fettstoffwechselstörungen. 2. Aufl. Stuttgart: Schattauer; 2001: 538-556
• 7 Gordon BR, Kelsey SF, Dau PC et al. Long-term effects of LDL apheresis using an automated dextransulfate cellulose adsorption system. Am J Cardiol 1998; 81: 407-411
• 8 Bosch T, Wendler T, Jaeger BR, Samtleben W. Clinical effects of direct adsorption of lipoprotein apheresis: beyond cholesterol reduction. Ther Apher Dial 2003; 7: 341-344
• 9 Bosch T, Wendler T, Jaeger BR, Samtleben W. Improvement of hemorheology by DALI apheresis: acute effects on plasma viscosity and erythrocyte aggregation in hypercholesterolaemic patients. Ther Apher 2001; 5: 372-376
• 10 Ringel. Lipoprotein Filtration by MONET: First Clinical Application in LDL Removal. Atherosclerosis 2010; 2 (Suppl. 11) 126